RecruitingPhase 2NCT04684368
2
studies recruiting now
as of 7 Sept 2026
28
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
29 Aug 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07148050
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Yolk sac tumor of central nervous system studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Yolk sac tumor of central nervous system study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Yolk sac tumor of central nervous system
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Gemcitabine (Gemzar)
Phase 2Oxaliplatin (Eloxatin)
Phase 2Paclitaxel (Abraxane)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).